1-[4-(二甲氨基)苯亚甲基氨基]-4-苯基硫脲的合成及手性晶体结构

对二甲氨基苯甲醛和苯基氨基硫脲缩合反应生成对二甲氨基苯甲醛缩氨基苯硫脲{1-[4-(dimethylamino)ben- zylidene]-4-phenylthiosemicarbazide}, 并从溶液中析出手性晶体. 元素分析、红外光谱、紫外光谱、核磁谱、质谱和X射线衍射测定其组成和结构. 晶体属正交晶系, P2₁2₁2₁空间群, a＝0.77038(14) nm, b＝1.1428(2) nm, c＝1.6726(3) nm, V＝1.4726(5) nm³, Z＝4, D_c＝1.346 g/cm³, F(000)＝632, μ＝0.219 mm^－1, 可观测点精修最终偏离因子: R＝0.0407, wR＝0.1157. 化合物的晶体结构和固态圆二色谱表明化合物在结晶过程中发生单一对映体的手性堆积.     

一种合成3,5-二氨基吡啶及3,5-二甲氧羰基氨基吡啶的新路线

以3,5-二甲基吡啶为起始原料,经氧化、酰胺化,酰胺在不同的霍夫曼降解条件下合成3,5-二氨基吡啶及3,5-二甲氧羰基氨基吡啶,总收率分别为64%和68%。利用1H NMR、MS/MS、IR等方法对各化合物的结构进行了表征。讨论了氧化反应及霍夫曼降解反应的主要影响因素。反应均在常压下进行,反应条件温和,后处理简单,效率高。     

高效液相色谱法测定烯草酮合成废液中4-二甲氨基吡啶含量

采用高效液相色谱法测定烯草酮合成废液中4-二甲氨基吡啶含量,使用BDS Hypersil C18不锈钢柱(250mm×4.6mm),以甲醇∶水∶磷酸=60∶39.75∶0.25为流动相,使用紫外检测器,在波长254nm下进行测定。实验测定4-二甲氨基吡啶加标回收率为97.7%,变异系数为3.33%,线性相关系数为0.9994。     

2,6-二溴-4-氨基吡啶的合成

从时间分辨荧光免疫分析双功能螯合剂合成需要出发,设计了2,6-二溴-4-氨基吡啶的合成路线.以2,6-二溴吡啶为起始原料,经过氧化、硝化和还原三步合成了该化合物,通过红外光谱、元素分析和熔点测定对其进行了表征.证明了该结构和合成方法的可靠性,并分别探讨了各步产物合成反应条件的影响,具有一定的参考价值.     

4-二甲氨基吡啶催化的1,3-二酮与3-丁炔-2-酮的苯环化反应

在4-二甲氨基吡啶(DMAP)催化下, 1,3-二酮与3-丁炔-2-酮可以区域选择性地合成四取代的苯, 该方法具有反应条件温和和操作简单等优点, 产物的结构通过IR, 1H NMR, 13C NMR, HRMS确证.     

4-二甲氨基吡啶催化合成含氟苯甲酸糖酯

以4－二甲氨基吡啶为催化剂由含氟苯甲酸与溴代乙酰糖催化酯化合成了4个新的含氟苯甲酸糖酯。其结构经IR，^1H NMR和MS确认，多数还作了^13C NMR测定。     

4—二甲氨基吡啶的合成及其催化的有机反应

综合了４－二甲氨基吡啶的制备方法及其对酰化、酯交换、烷基化等有机反应的催化作用，并探讨其在精细化工诸领域的应用前景。参考文献５０篇。     

1-[4-(二甲氨基)苯亚甲基氨基]-4-苯基硫脲的另一个手性对映体晶体结构

对-二甲氨基苯甲醛和苯基氨基硫脲缩合反应生成1-[4-(二甲氨基)苯亚甲基氨基]-4-苯基硫脲(DMB), 产物能从溶液中析出单一手性对映体晶体. 用单晶X射线衍射技术测定了它的绝对构型, 晶体属正交晶系, P2₁2₁2₁空间群, a＝0.7870(2) nm, b＝1.1560(2) nm, c＝1.6668(3) nm, V＝1.5164(5) nm³, Z＝4, D_c＝1.307 g/cm³, F(000)＝632, μ＝0.213 mm^－1, 2557个可观测点[I＞2s(I)]精修的最终残差因子: R＝0.0409, wR＝0.1061, Flack参数为0.00(9), 能够确定绝对构型. 化合物的晶体结构和大宗粉末样品的固体圆二色谱表明化合物在结晶过程中发生单一对映体的手性堆积.     

2-氨基-4-氟吡啶合成工艺研究

2-氨基-4-氟吡啶是制备酪氨酸激酶抑制剂、PI3K抑制剂和醛固酮合酶抑制剂等酶抑制剂的重要中间体.已报道的制备方法均存在一些缺陷,难以满足工业化生产.本文以4-氯吡啶-2-甲酰胺为原料,经酰胺脱水、卤素交换、氰基水解、霍夫曼降解等反应得到目标化合物.产物结构经1 H NMR和GC-MS确证.本文采用的合成方法简单、反...     

4－二甲氨基吡啶的合成及其催化的有机反应

综述了４－二甲氨基吡啶（ＤＭＡＰ）的制备方法及其对酰化、酯交换、烷基化等有机反应的催化作用，并探讨其在精细化工诸领域的应用前景。参考文献５０篇。     

Facile and Simple Synthesis of Novel 1-Methyl-2-(2-substituted-oxazol-4-yl)-1H-benzimidazole Derivatives

Novel 1-methyl-2-(2-substituted-oxazol-4-yl)-1H-benzimidazole derivatives were obtained in good yields and purity by treating corresponding 2-benzimidazolyl esters with acetamide in the presence of BF₃-etherate, a Lewis acid.     

4-(4'-丙基环己基)环己醇的合成

钌/碳催化剂应用于4-(4'-丙基环己基)苯酚(3PCO)的加氢反应,合成了4-(4'-丙基环己基)环己醇.以环己烷为溶剂,在98℃/2MPa,3PCO的转化率为100.0%,催化剂可以重复使用两次.     

N-(4-芳基-噻唑-2-基)--(1H-苯并三唑-1-基)苯乙酮腙类衍生物的合成

以苯并三唑为原料与-溴代芳基乙酮缩合得-(1H-苯并三唑-1-基)芳基乙酮, 再与硫代氨基脲缩合得到新的缩氨基硫脲. 然后分别与5种ω-溴代芳基乙酮环化得到一系列新的含苯并三唑和噻唑环的苯乙酮腙类Schiff碱. 其结构经IR, ¹H NMR, ¹³C NMR和MS及元素分析确证.     

Efficient Synthesis of (S)-3-(4-Fluorophenyl)morpholin-2-one,a Key Chiral Intermediate of Aprepitant

A facile, economical, and practical method for the preparation of (S)-3-(4-fluorophenyl)morpholin-2-one [(S)-9] has been developed from ethyl 2-(4-fluorophenyl)-2-oxoacetate (7) in three steps through cyclization, hydrogenation, and resolution, providing a new and convenient access to the key intermediate of antiemetic drug aprepitant.     

Synthesis of 3-[4-(1-Benzofuran-2-yl)-1,3-thiazol-2-yl]-2-(4-aryl)-1,3-thiazolidin-4-one Derivatives as Biological Agents

A protocol for the synthesis of 3-[4-(1-benzofuran-2-yl)-1,3-thiazol-2-yl]-2-(4-aryl)-1,3-thiazolidin-4-one derivatives (5a–e) has been developed from 1-(1-benzofuran-2-yl)-2-bromoethanone (2),which served as a key intermediate for the synthesis of the title compounds. The reaction of compound 2 with thiourea furnished 4-(1-benzofuran-2-yl)-1,3-thiazol-2-amine 3, which upon further reaction with various aromatic aldehydes, gave Schiff bases 4a–e. These Schiff bases, when treated with thioacetic acid in the presence of catalytic amount of anhydrous ZnCl₂, yielded thiazolidinone derivatives 5a–e. All the newly synthesized compounds have been characterized by analytical and spectral data and screened for their antimicrobial and analgesic activity.

Supplemental materials are available for this article. Go to the publisher's online edition of Phosphorus, Sulfur, and Silicon and the Related Elements to view the free supplemental file.     

Synthesis of 2-(pyrimidin-4-yl)indoles

The synthesis of 2-substituted isomers of the meridianins, a familiy of bioactive indole alkaloids isolated from the tunicate Aplidium meridianum, was undertaken. The synthetic route comprises six steps, with a microwave promoted Fischer cyclization as the key reaction.     

Synthesis, structural characterization and reactivity of the amino borane 1-(NPh2)-2-[B(C6F5)2]C6H4

The bright red title compound 1 was synthesized from (2-lithiophenyl)diphenylamine and bis(pentafluorophenyl)boron chloride. Its reactions with small acids like H₂O and HCl proceeded easily giving zwitterionic compounds. For 1 and its water adduct 2 the crystal structures were determined, the latter featuring an ammonium borate structure containing a short intramolecular hydrogen bond bridge. Treatment of 1 with Jutzi's acid, [H(OEt₂)₂][B(C₆F₅)₄], did not result in protonation of the nitrogen, but reaction of 1 with LiH in the presence of 12-crown-4, led to the isolation of the aminoborate [1-(Ph₂N)-2-{B(H)(C₆F₅)₂}C₆H₄][Li(12-crown-4)] (3). Borohydride 3 reacted with Jutzi's acid to regenerate 1 and liberate hydrogen.     

Synthesis of Geminally Activated 4-(Furan-2-yl)- and 4-(Thiophen-2-yl)-1-nitrobuta-1,3-dienes

The condensation of 3-(furan-2-yl)- and 3-(thiophen-2-yl)prop-2-enals with nitro-substituted CH acids, namely ethyl nitroacetate, nitroacetone, nitroacetophenone, and nitroacetonitrile, afforded a series of geminally activated nitro dienes, 4-(furan-2-yl)- and 4-(thiophen-2-yl)-1-nitrobuta-1,3-dienes. The product structure was confirmed by NMR and IR spectroscopy.

     

反-4-(反-4'-正丙基环已基)环已醇的合成与表征

环己烷类液晶因具有高度的稳定性,较宽的相列相温区而受到人们的青睐。反-4-(反-4’-正丙基环己基)环己醇(trans-3HHE)是一种合成环己烷类液晶的重要中间体,它可通过酶选择性催化和顺式构型异构化二种方法合成。文献报道顺式构型异构化法是：4-(反-4’-正丙基环己基)苯酚以铑／碳或铑／氧化铝为催化剂,在酸性介质条件下进行加氢反应,     

Synthesis of stereoisomeric 4-(2-methylindolin-1-yl)- and 4-(2-methylindol-1-yl) derivatives of glutamic acid

The reaction of dimethyl (2S,4RS)-N-phthaloyl-4-bromoglutamate with 2-methylindoline afforded diastereomeric 4-(2-methylindolin-1-yl)-(S)-glutamic acid derivatives, whose oxidation gave rise to 4-(2-methylindol-1-yl)-(S)-glutamic acid derivatives.